Cornell scientists have created microscopic beads that efficiently recover heparin, an ingredient used as a pharmaceutical blood thinner, from agricultural animals.
Political scientist Steven Levitsky, the Sundance Institute’s Keri Putnam and biomedical engineer Stephen Quake have joined the ranks of leading scholars and public intellectuals at Cornell as Andrew Dickson White Professors-at-Large.
New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.
A new technique that combines electricity and chemistry offers a way for pharmaceuticals to be manufactured in an easily scaled-up and sustainable way.
A new method for testing urinary tract infections yields more information than what conventional methods can offer, according to new research.
The College of Agriculture and Life Sciences announced Aug. 1 the renaming of the New York State Agricultural Experiment Station to Cornell AgriTech.
The Seed System Initiative, implemented by Cornell’s Delivering Genetic Gain in Wheat project in 2017-18, benefits wheat farmers in Nepal.
A study describes for the first time how a promising FDA-approved cancer drug – currently in clinical trials – works to effectively kill cancer cells.
Cornell experts from Ithaca and New York City gathered June 26-27 at the College of Veterinary Medicine for the Immunology in Health and Disease Symposium.